Thesis
NVO is transitioning from a completed Cycle Wave 2 into a new multi-year expansion phase. The long-term bull structure remains intact, with fundamentals now acting as a catalyst for the next cycle leg.
Context
- Weekly timeframe
- Primary bull trend originates from the 2009 GFC low (< $1)
- Cycle Wave 1 completed in July 2024
- Deep corrective Cycle Wave 2 now appears complete
What I see
-Structural reversal underway from long-term trend support
- Price stabilizing in a major accumulation / buy zone
- New Wegovy pill acts as a fundamental trigger aligning with the technical reversal
- Momentum and structure support the start of Cycle Wave 3
What matters now
- Holding the current base keeps the Cycle Wave 3 thesis intact
- This phase is about accumulation, not timing short-term moves
Buy / Accumulation zone
- Current zone remains suitable for long-term positioning
- This is where multi-year risk/reward is defined
Targets
- Cycle Wave 3 (1.618 Fib): ~$273. Expected around early 2029. Approx. +450% from the buy area
- Cycle Wave 5: ~$415. Expected around 2033. Approx. +730% from the buy area
Income
- Dividend yield ~2.1% adds meaningful carry while holding
Conclusion
Strong technical cycle alignment + improving fundamentals make
NVO a compelling long-term hold. This is a position built to be held through volatility, not traded.
Context
- Weekly timeframe
- Primary bull trend originates from the 2009 GFC low (< $1)
- Cycle Wave 1 completed in July 2024
- Deep corrective Cycle Wave 2 now appears complete
What I see
-Structural reversal underway from long-term trend support
- Price stabilizing in a major accumulation / buy zone
- New Wegovy pill acts as a fundamental trigger aligning with the technical reversal
- Momentum and structure support the start of Cycle Wave 3
What matters now
- Holding the current base keeps the Cycle Wave 3 thesis intact
- This phase is about accumulation, not timing short-term moves
Buy / Accumulation zone
- Current zone remains suitable for long-term positioning
- This is where multi-year risk/reward is defined
Targets
- Cycle Wave 3 (1.618 Fib): ~$273. Expected around early 2029. Approx. +450% from the buy area
- Cycle Wave 5: ~$415. Expected around 2033. Approx. +730% from the buy area
Income
- Dividend yield ~2.1% adds meaningful carry while holding
Conclusion
Strong technical cycle alignment + improving fundamentals make
관련 발행물
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
